Health Ministry reports 398 new COVID-19 cases, 404 recoveries, 20 deaths

JEDDAH: China’s Sinovac coronavirus vaccine is set to be administered to Saudi patients after passing third stage clinical trials, but remains on hold until approved by the Saudi Food and Drug Authority.

Read More : Check Exit Re-Entry Visa status Online without Absher

King Abdullah International Medical Research Center (KAIMRC) signed an agreement with China’s Sinovac Biotech to receive a vaccine for COVID-19 to be distributed to about 7,000 health workers.

The vaccine has passed the third stage of trials at the King Abdullah Center for the National Guard.